ACOG District II : 2013 Annual Meeting Evaluation

Final Assessment

 
The ACOG District II 2013 Annual Meeting provides the opportunity to facilitate the professional development of women’s health care professionals by offering a scientific program designed to provide comprehensive clinical skills-based education.

District II’s mission is to provide its members with the latest skills, knowledge, and resources to offer the highest quality health care for women.

Over the past three days, participants have engaged in an interactive program that included:

* Ample case studies
* Group and panel discussions
* Compelling presentations from distinguished faculty across the country

Please complete this Final Assessment to help inform future programming.
1. Yvonne Thornton, MD, MPH, FACOG, FACS
1 (poor)2345 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias
2. Disclosed whether or not relationship with industry exists
3. Would you like to hear this speaker again?
4. Scott Hayworth, MD, FACOG
1 (poor)2345 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias
5. Disclosed whether or not relationship with industry exists
6. Would you like to hear this speaker again?
7. James N. Martin, Jr., MD, FACOG
1 (poor)2345 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias
8. Disclosed whether or not relationship with industry exists
9. Would you like to hear this speaker again?
10. Mark S. Defrancesco, MD, MBA, FACOG
1 (poor)2345 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias
11. Disclosed whether or not relationship with industry exists
12. Would you like to hear this speaker again?
13. Mary E. D'Alton, MD, FACOG
1 (poor)2345 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias
14. Disclosed whether or not relationship with industry exists
15. Would you like to hear this speaker again?
16. John P. Keats, MD, CPE, FACOG, FACPE
1 (poor)2345 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias
17. Disclosed whether or not relationship with industry exists
18. Would you like to hear this speaker again?
19. Cynthia Chazotte, MD, FACOG
1 (poor)2345 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias
20. Disclosed whether or not relationship with industry exists
21. Would you like to hear this speaker again?
22. Ronald T. Burkman, MD, FACOG
1 (poor)2345 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias
23. Disclosed whether or not relationship with industry exists
24. Would you like to hear this speaker again?
25. Jason D. Wright, MD, FACOG
1 (poor)2345 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias
26. Disclosed whether or not relationship with industry exists
27. Would you like to hear this speaker again?
28. Mark I. Evans, MD, FACOG, FACMG
1 (poor)2345 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias
29. Disclosed whether or not relationship with industry exists
30. Would you like to hear this speaker again?
31. Susan Klugman, MD, FACOG, FACMG
1 (poor)2345 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias
32. Disclosed whether or not a relationship with industry exists
33. Would you like to hear this speaker again?
34. Noah D. Kauff, MD, FACOG
1 (poor)2345 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias
35. Disclosed whether or not relationship with industry exists
36. Would you like to hear this speaker again?
37. Angela G. Arnold, MS, CGC
1 (poor)2345 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias
38. Disclosed whether or not relationship with industry exists
39. Would you like to hear this speaker again?
40. Robert A. Soslow, MD
1 (poor)2345 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias
41. Disclosed whether or not relationship with industry exists
42. Would you like to hear this speaker again?
43. Laura MacIsaac, MD, MPH, FACOG
1 (poor)2345 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias
44. Disclsoed whether or not relationship with industry exists
45. Would you like to hear this speaker again?
46. Anthony T. DiBenedetto, MD, FACS
1 (poor)2345 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias
47. Disclsoed whether or not relationship with industry exists
48. Would you like to hear this speaker again
49. Andrew M. Kaunitz, MD, FACOG
1 (poor)2345 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias
50. Disclosed whether or not relationship with industry exists
51. Would you like to hear this speaker again?
52. Kunle Odunsi, MD, PhD
1 (poor)2345 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias
53. Disclosed whether or not relationship with industry exists
54. Would you like to hear this speaker again?
55. Haywood L. Brown, MD, FACOG
1 (poor)2345 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias
56. Disclsoed whether or not relationship with industry exists
57. Would you like to hear this speaker again?
58. Yitzchak M. Binik, PhD
1 (poor)2345 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias
59. Disclosed whether or not relationship with industry exists
60. Would you like to hear this speaker again?
61. Linda Bradley, MD, FACOG
1 (poor)2345 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias
62. Disclosed whether or not relationship with industry exists
63. Would you like to hear this speaker again?
64. Nicholas Kulbida, MD, FACOG
1 (poor)2345 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias
65. Disclosed whether or not relationship with industry exists
66. Would you like to hear this speaker again?
67. Joanne Stone, MD, FACOG
1 (poor)2345 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias
68. Disclosed whether or not relationship with industry exists
69. Would you like to hear this speaker again?
70. James Goldberg, MD, FACOG
1 (poor)2345 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias
71. Disclosed whether or not relationship with industry exists
72. Would you like to hear this speaker again?
73. Cynthia Gymafi-Bannerman, MD, FACOG
1 (poor)2345 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias
74. Disclosed whether or not relationship with industry exists
75. Would you like to hear this speaker again?
76. Angela Bianco, MD, FACOG
1 (poor)2345 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias
77. Disclosed whether or not relationship wtih industry exists
78. Would you like to hear this speaker again?
79. Richard L. Berkowitz, MD, FACOG
1 (poor)2345 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias
80. Disclosed whether ot not relationship with industry exists
81. Would you like to hear this speaker again?
82. Elliott K. Main, MD, FACOG
1 (poor)2345 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias
83. Disclosed whether or not relationship with faculty exists
84. Would you like to hear this speaker again?
85. "Ask the Experts" Panel Discussion
1 (poor)2345 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias
86. Disclosed whether or not relationship with industry exists
87. Would you like to hear this speaker again?
88. This program was:
89. The entire program...
1 (strongly disagree)2345 (strongly agree)
Was well-organized
Was consistent with course objectives
Allowed sufficient time for discussion
Adhered to printed meeting schedule
Meeting facilities were conducive to learning
90. Final program grade (5 = best score)
91. The hotel facilities
1 (very dissatisfied)2345 (very satisfied)
How satisfied were you with this facility?
How satisfied were you with the cost of this facility?
92. Preferred topics for future courses (indicate if of interest to you):
93. What is your preferred meeting site? (indicate one)
94. What is your preferred meeting region?
95. What are the factors influencing your choice?
YesNo
Hotel costs
Course content
Availability of direct transportation
Facilities for family
96. Preferred meeting days: the meeting should start on...
97. COMMENTS: If you have comments on any aspects of this program that were not covered by this evaluation, please write them within this box.
Powered by SurveyMonkey
Check out our sample surveys and create your own now!